Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.

[1]  R. Nussenblatt,et al.  Ocular manifestations of central nervous system lymphoma , 2001, Current opinion in oncology.

[2]  J. Dürig,et al.  Differential expression of chemokine receptors in B cell malignancies , 2001, Leukemia.

[3]  L. Jampol,et al.  Variations in the presentation of primary intraocular lymphoma: case reports and a review. , 2001, Survey of ophthalmology.

[4]  L. Liotta,et al.  Laser Capture Microdissection , 2001, Current protocols in cell biology.

[5]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[6]  B. Rollins,et al.  Chemokines and disease , 2001, Nature Immunology.

[7]  L. Kanz,et al.  Functional response of leukaemic blasts to stromal cell‐derived factor‐1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia , 2000, British journal of haematology.

[8]  Hiroshi Takamori,et al.  Autocrine Growth Effect of IL-8 and GRO&agr; on a Human Pancreatic Cancer Cell Line, Capan-1 , 2000, Pancreas.

[9]  S. Fujita,et al.  Stromal cells in lymph nodes attractB‐lymphoma cells via production ofstromal cell‐derived factor‐1 , 2000, European journal of haematology.

[10]  James J. Campbell,et al.  Developmental Switches in Chemokine Response Profiles during B Cell Differentiation and Maturation , 2000, The Journal of experimental medicine.

[11]  S. Pals,et al.  Cell adhesion receptors in lymphoma dissemination. , 2000, Blood.

[12]  C. Berek,et al.  CXCR5‐deficient mice develop functional germinal centers in the splenic T cell zone , 2000, European journal of immunology.

[13]  L. Deangelis,et al.  Update on the management of primary CNS lymphoma. , 2000, Oncology.

[14]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[15]  D. Dorfman,et al.  The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. , 2000, Blood.

[16]  L. Kanz,et al.  Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1) , 1999, Leukemia.

[17]  T. Kipps,et al.  Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. , 1999, Blood.

[18]  J. Westwick,et al.  Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. , 1999, The Journal of clinical investigation.

[19]  S. Whitcup,et al.  Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogeneous IgH gene rearrangement. , 1999, Archives of ophthalmology.

[20]  M. Schabet.  Epidemiology of Primary CNS Lymphoma , 1999, Journal of Neuro-Oncology.

[21]  W. Paulus.  Classification, Pathogenesis and Molecular Pathology of Primary CNS Lymphomas , 1999, Journal of Neuro-Oncology.

[22]  L. Trentin,et al.  The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. , 1999, The Journal of clinical investigation.

[23]  C. Mackay,et al.  Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. , 1998, Immunology today.

[24]  A. Zlotnik,et al.  T-cell subsets: Chemokine receptors guide the way , 1998, Current Biology.

[25]  R. Nussenblatt,et al.  Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. , 1998, Ophthalmology.

[26]  R. Bronson,et al.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R Bonecchi,et al.  Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. , 1998, Journal of immunology.

[28]  T. Matsuo,et al.  TWO TYPES OF INITIAL OCULAR MANIFESTATIONS IN INTRAOCULAR‐CENTRAL NERVOUS SYSTEM LYMPHOMA , 1998, Retina.

[29]  Masahiko Kuroda,et al.  Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development , 1998, Nature.

[30]  T. Kishimoto,et al.  A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. , 1998, Seminars in immunology.

[31]  T. Springer,et al.  B Lymphocyte Chemotaxis Regulated in Association with Microanatomic Localization, Differentiation State, and B Cell Receptor Engagement , 1998, The Journal of experimental medicine.

[32]  Jason G. Cyster,et al.  A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 , 1998, Nature.

[33]  M. Baggiolini,et al.  B Cell–attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1/CXCR5 , 1998, The Journal of experimental medicine.

[34]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[35]  C. Mackay,et al.  Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. , 1997, Science.

[36]  N. Copeland,et al.  TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. , 1997, Immunity.

[37]  C. Mackay,et al.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. Wolf,et al.  A Putative Chemokine Receptor, BLR1, Directs B Cell Migration to Defined Lymphoid Organs and Specific Anatomic Compartments of the Spleen , 1996, Cell.

[39]  B. Premack,et al.  Chemokine receptors: Gateways to inflammation and infection , 1996, Nature Medicine.

[40]  T. Springer,et al.  A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) , 1996, The Journal of experimental medicine.

[41]  Bernhard Moser,et al.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.

[42]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[43]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[44]  H. Kikutani,et al.  Molecular cloning and structure of a pre-B-cell growth-stimulating factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Nussenblatt,et al.  Intraocular lymphoma. Clinical and histopathologic diagnosis. , 1993, Ophthalmology.

[46]  L. Deangelis,et al.  The clinical spectrum of ocular lymphoma , 1993 .

[47]  M. Blumenkranz,et al.  Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). , 1992, Ophthalmology.

[48]  R. Nussenblatt,et al.  Immunohistochemistry findings in primary intraocular lymphoma. , 1991, American journal of ophthalmology.

[49]  P. Burger,et al.  Increasing incidence of primary brain lymphoma in the US , 1988, Cancer.

[50]  W. Green,et al.  Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature , 1983, Cancer.

[51]  A. Nathan.  T-Cell Subsets , 1982 .

[52]  D. Albert,et al.  3. Intraocular Reticulum Cell Sarcoma , 1980 .

[53]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[54]  K. Kawabata,et al.  A CXC chemokine SDF-1/PBSF: a ligand for a HIV coreceptor, CXCR4. , 1999, Advances in immunology.

[55]  R. Burgstahler,et al.  Regulation of expression of chemokine receptor BLR1/CXCR5 during B cell maturation. , 1999, Current topics in microbiology and immunology.

[56]  C. Foster,et al.  Primary Intraocular Lymphoma , 1997, International ophthalmology clinics.

[57]  S. Dubinett,et al.  Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[58]  D. Arenberg,et al.  Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. , 1995, Biochemical and biophysical research communications.

[59]  C. Barr,et al.  Intraocular reticulum-cell sarcoma: clinico-pathologic study of four cases and review of the literature. , 1975, Survey of ophthalmology.